Ralliant Corporation (NYSE:RAL) Short Interest Up 32.4% in December

31 Dec 2025, 23:48 by Scott Moore · The Cerbat Gem

Ralliant Corporation (NYSE:RAL – Get Free Report) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 2,784,414 shares, an increase of 32.4% from the November 30th total of 2,102,958 shares. Based on an average daily volume of 1,453,677 shares, the days-to-cover ratio is presently 1.9 days. Approximately 2.5% of the shares of the stock are short sold. Approximately 2.5% of the shares of the stock are short sold. Based on an average daily volume of 1,453,677 shares, the days-to-cover ratio is presently 1.9 days.

Institutional Investors Weigh In On Ralliant

Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its stake in Ralliant by 10.7% during the third quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock worth $637,995,000 after purchasing an additional 1,415,327 shares during the period. Dodge & Cox purchased a new stake in shares of Ralliant during the 2nd quarter valued at approximately $523,571,000. Viking Global Investors LP purchased a new stake in shares of Ralliant during the 2nd quarter valued at approximately $257,200,000. State Street Corp acquired a new position in Ralliant in the second quarter valued at approximately $213,096,000. Finally, Flossbach Von Storch SE grew its position in Ralliant by 1.7% in the third quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock worth $181,605,000 after acquiring an additional 67,963 shares during the period.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. Truist Financial initiated coverage on shares of Ralliant in a research report on Friday, December 12th. They set a “buy” rating and a $62.00 price target for the company. Royal Bank Of Canada boosted their price objective on Ralliant from $45.00 to $52.00 and gave the stock a “sector perform” rating in a research note on Friday, November 7th. Morgan Stanley assumed coverage on Ralliant in a report on Tuesday, September 2nd. They set an “overweight” rating and a $55.00 target price for the company. Oppenheimer raised their target price on Ralliant from $55.00 to $60.00 and gave the company an “outperform” rating in a research report on Monday, December 15th. Finally, Citigroup upgraded Ralliant from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $53.00 to $61.00 in a research report on Monday, December 8th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Ralliant currently has a consensus rating of “Moderate Buy” and an average price target of $57.89.

Get Our Latest Report on RAL

Ralliant Stock Down 0.4%

Shares of Ralliant stock traded down $0.23 on Wednesday, hitting $50.99. 761,887 shares of the company were exchanged, compared to its average volume of 1,332,022. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39. The stock’s 50-day moving average is $48.17. The stock has a market cap of $5.75 billion and a PE ratio of 40.15. Ralliant has a 1-year low of $40.70 and a 1-year high of $55.08.

Ralliant (NYSE:RAL – Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.58 by $0.02. The company had revenue of $529.10 million during the quarter, compared to analyst estimates of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Monday, December 8th were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Monday, December 8th. Ralliant’s payout ratio is currently 15.75%.

About Ralliant

(Get Free Report)

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.